Associations between changes in glucagon‐like peptide‐1 and bodyweight reduction in patients receiving acarbose or metformin treatment
Na Wang(Xihua University), Wenying Yang(China-Japan Friendship Hospital), Xin Wang(Johns Hopkins University), Bo Zhang(Gansu Agricultural University), Xiaoyan Xing(China-Japan Friendship Hospital), Jinping Zhang(Soochow University), Zhaojun Yang(China-Japan Friendship Hospital)
Cited by 11
Related Papers
<i>TERT</i> promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA
|Cancer|2014|114
The nucleoprotein of influenza A virus inhibits the innate immune response by inducing mitophagy
|Autophagy|2023|102
Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1
|PLoS ONE|2013|89
Recent Advances in the Management of Diabetic Kidney Disease: Slowing Progression
|International Journal of Molecular Sciences|2024|80
IL-9 Contributes to Immunosuppression Mediated by Regulatory T Cells and Mast Cells in B-Cell Non-Hodgkin’s Lymphoma
|Journal of Clinical Immunology|2011|59